Location
Netherlands, Europe
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Pharmaceuticals
About Investor
Hakan Goker is a Managing Director at M Ventures (Merck), heading the Biotechnology Investments portfolio, which covers Healthcare and Life Sciences Tools and Diagnostics. He focuses on seed through Series B investments in Pharmaceuticals, BioTech, Health IT, Health & Hospital Services, Digital Health, and Therapeutics, with investment ranges between $100K and $5.0M. Goker holds a Ph.D. in oncology from the Institute of Cancer Research, University of London, and is based in Amsterdam, Netherlands.
Previous investments
TRIMTECH Therapeutics
31M |2025
Asceneuron
100M |2024
31M |2015
iOnctura
86M |2024
6M |2020
17M |2020
2017
Similar Investors
JG
Joaquin Gomez
United Kingdom, Europe
$50K - $1M
Pre Seed
,Seed
,WT
William Tunstall-Pedoe
United Kingdom, Europe
$10K - $500K
Pre Seed
,Seed
,CJ
Christoph Janz
Germany, Europe
$580K - $3.5M
Pre Seed
,Seed
,IT
Igor Tikhturov
United Kingdom, Europe
$100K - $5M
Pre Seed
,Seed
,EV
Eze Vidra
United Kingdom, Europe
$300K - $1.5M
Pre Seed
,Seed
,PL
Pierre-Eric Leibovici
France, Europe
$500K - $10M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.